FDA gives emergency approval to COVID-19 antibody serum used to treat Trump
The approval of Regeneron’s treatment is second in a month.
The Food and Drug Administration on Saturday evening gave emergency approval for a COVID-19 antibody treatment used to treat President Trump.
Regeneron’s antibody serum was authorized for treating mild to moderate coronavirus in adults, as well as children 12 years or older who have a high risk of progressing to severe disease.
Regeneron applied for emergency FDA approval in October after Trump praised the treatment in a Twitter video.
The FDA earlier this month also issued an emergency use authorization for another COVID-19 antibody treatment made by Eli Lilly.
News, Not Noise
- Judge Emmet Sullivan still refusing to dismiss Michael Flynn case
- Amistad Project argues in new report that Electoral College deadlines are not set in stone
- GOP Rep. Cloud says Justice, FBI putting up 'roadblocks' in efforts to verify voter fraud
- Dominion contractor at Detroit counting center says thousands of ballots were scanned multiple times
- Arizona Senate president, House leader call for audit of Dominion machines in Maricopa County